RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 83 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2014. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $982,000 | +67.0% | 109,460 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $588,000 | +16.7% | 109,460 | 0.0% | 0.00% | – |
| Q1 2016 | $504,000 | -20.0% | 109,460 | -9.7% | 0.00% | -100.0% |
| Q4 2015 | $630,000 | -14.1% | 121,160 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $733,000 | -61.7% | 121,160 | -0.1% | 0.00% | -50.0% |
| Q2 2015 | $1,915,000 | +60.8% | 121,300 | +10.7% | 0.00% | +100.0% |
| Q1 2015 | $1,191,000 | +3.3% | 109,600 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,153,000 | +9.7% | 109,600 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,051,000 | -17.0% | 109,600 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,266,000 | +15.3% | 109,600 | -0.2% | 0.00% | 0.0% |
| Q1 2014 | $1,098,000 | -23.1% | 109,837 | +0.2% | 0.00% | 0.0% |
| Q4 2013 | $1,427,000 | -11.6% | 109,600 | +1.4% | 0.00% | -50.0% |
| Q3 2013 | $1,615,000 | +159.2% | 108,100 | +62.1% | 0.00% | +100.0% |
| Q2 2013 | $623,000 | – | 66,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |